Intravitreal angiostatisk behandling af okulær sygdom

Lou-Ann Christensen Andersen, Lasse Jørgensen Cehofski, Jakob Grauslund

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Intraocular vascular diseases like neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion are associated with decline in vision if left untreated. Anti-vascular endothelia growth factor (VEGF) agents originally developed for cancer treatment were the beginning of a new treatment regime for intraocular vascular diseases. Ambiguous results exist regarding adverse effects but are considered limited. In the future, anti-VEGF agents are likely to be used for treatment of proliferative diabetic retinopathy, neovascular glaucoma and premature retinopathy.
Bidragets oversatte titelIntravitreal angiostatic treatment of ocular vascular diseases
OriginalsprogDansk
ArtikelnummerV04190256
TidsskriftUgeskrift for Laeger
Vol/bind182
Udgave nummer10
Antal sider4
ISSN0041-5782
StatusUdgivet - 2020

Fingeraftryk Dyk ned i forskningsemnerne om 'Intravitreal angiostatisk behandling af okulær sygdom'. Sammen danner de et unikt fingeraftryk.

Citationsformater